NDC 64950-174 – RenThyroid
Levothyroxine 76 ug/1; Liothyronine 18 ug/1 · Tablet · Oral
Product NDC64950-174
Product details
- Brand name
- RenThyroid
- Generic name
- LEVOTHYROXINE and LIOTHYRONINE
- Labeler
- Genus Lifesciences
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketed since
- March 1, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Active ingredients
- Levothyroxine 76 ug/1
- Liothyronine 18 ug/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 64950-174-01 | 100 TABLET in 1 BOTTLE (64950-174-01) | Mar 1, 2025 |
| 64950-174-09 | 90 TABLET in 1 BOTTLE (64950-174-09) | Mar 1, 2025 |
| 64950-174-14 | 14 TABLET in 1 BOTTLE (64950-174-14) | Mar 1, 2025 |
Other RenThyroid products
- 64950-170 Levothyroxine 9.5 ug/1; Liothyronine 2.25 ug/1 · Tablet · Genus Lifesciences
- 64950-171 Levothyroxine 19 ug/1; Liothyronine 4.5 ug/1 · Tablet · Genus Lifesciences
- 64950-172 Levothyroxine 38 ug/1; Liothyronine 9 ug/1 · Tablet · Genus Lifesciences
- 64950-173 Levothyroxine 57 ug/1; Liothyronine 13.5 ug/1 · Tablet · Genus Lifesciences
- 64950-175 Levothyroxine 114 ug/1; Liothyronine 27 ug/1 · Tablet · Genus Lifesciences
- 64950-179 Levothyroxine 28.5 ug/1; Liothyronine 6.75 ug/1 · Tablet · Genus Lifesciences
- 64950-180 Levothyroxine 47.5 ug/1; Liothyronine 11.25 ug/1 · Tablet · Genus Lifesciences